Victoria Forster, Contributor

Author's posts

New ‘Double Hit’ Strategy May Provide New, Minimally Toxic Therapies For Breast Cancer

New research has identified a potential new target for therapies that could be used in triple-negative breast cancer, while sparing healthy cells.

Could Viruses Attacking The Microbiome Be Responsible For Inflammatory Bowel Disease?

Researchers have discovered a correlation between viruses and inflammation in a mouse model of inflammatory bowel disease.

Liquid Biopsy Controversy Rages On

Last year, researchers showed that two commercially available liquid biopsy tests for cancer produced drastically different results. Now the companies and researchers are in a war of words to prove who is right.

Common Chemotherapy Drug Is More Effective When Given With Dietary Supplement In Mice

New research suggests one of the oldest cancer chemotherapy agents in the world could be improved by supplementing with a common dietary amino acid.

Ketogenic Diet Improves Response To Cancer Drug In Mice, But Alone May Accelerate Cancer

A ketogenic diet, which is high-fat, adequate protein and low-carb has increased the effect of a class of cancer drugs in mice.

Ketogenic Diet Improves Response To Cancer Drug In Mice, But Alone May Accelerate Cancer

A ketogenic diet, which is high-fat, adequate protein and low-carb has increased the effect of a class of cancer drugs in mice.

FDA Approves First-Ever Medication Containing Ingredient Directly Purified From Cannabis

A cannabis-based drug for two childhood epilepsy syndromes has become the first drug containing a purified cannabis compound to gain FDA approval.

Naturally-Derived Cancer Drugs Provide Clues As To How Microbiome May Cause Chemotherapy Resistance

Scientists have discovered a new way in which bacteria residing in the human gut may be able to contribute to chemotherapy resistance.

New $100 Genetic Test Identifies Men Who Have Vastly Increased Chance Of Developing Prostate Cancer

A new saliva-based test for prostate cancer can identify men at increased risk of developing the disease at a cost of less than $100.